Based on the observed sensitization following HAT, but not bromodomain inhibition, and the lack of evidence for this phenomenon being solely gene-expression dependent, we further investigated histone-acetylation status in HNSCC cell lines following combination treatment. This evidence concerns the gene TMPRSS11D and head and neck squamous cell carcinoma.